Generic Drug Development CDMO

Introduction to Dexamethasone Phosphate vs Acetate When comparing Dexamethasone Phosphate vs Acetate, the key differences involve solubility, pharmacokinetics, ester hydrolysis […]

Introduction: A Dexamethasone Injectable CRO plays a critical role in helping pharmaceutical companies successfully develop generic and complex injectable formulations

Introduction: Dexamethasone Injection Generic Development is a complex but highly valuable opportunity for pharmaceutical companies developing injectable generic products. Because

Introduction Selecting the right partner is a critical step in generic drug development. Pharmaceutical companies must Choose Right CRO/CDMO for

Introduction: This Unknown Impurity Identification ANDA Case Study explains how an unidentified impurity discovered during stability testing was successfully characterized

Introduction: Understanding the Requirements for ANDA Submission Generic Drugs is essential for any pharmaceutical company planning to enter the U.S.

Introduction: When evaluating CRO vs In-house ANDA Development, it’s essential to understand that both approaches aim to successfully develop generic

Introduction: The analytical requirements ANDA generic drugs must fulfill are the foundation of successful generic drug approval. In an ANDA

Introduction: The Generic Drug Development Process ANDA is a scientifically driven pathway that enables pharmaceutical companies to develop affordable and